Similar articles for PMID: 2071784

Year	Number of Results
1948	1
1950	1
1953	1
1967	1
1968	1
1972	2
1973	1
1974	1
1975	2
1976	3
1977	3
1978	1
1979	3
1980	5
1981	7
1982	14
1983	7
1984	8
1985	5
1986	3
1987	9
1988	10
1989	7
1990	4
1991	5
1992	3
1993	2
1994	2
1995	7
1996	7
1997	7
1998	4
1999	2
2001	2
2002	3
2003	4
2004	4
2005	1
2006	7
2008	3
2009	4
2010	3
2011	4
2012	4
2013	4
2014	6
2015	5
2016	6
2017	1
2018	2
2019	1
2020	1
2022	2
2023	1
2024	0

1

Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts.

Bousquet J, Becker WM, Hejjaoui A, Chanal I, Lebel B, Dhivert H, Michel FB. Bousquet J, et al. J Allergy Clin Immunol. 1991 Jul;88(1):43-53. doi: 10.1016/0091-6749(91)90299-4. J Allergy Clin Immunol. 1991. PMID: 2071784 Clinical Trial.

2

Clinical and immunologic reactivity of patients allergic to grass pollens and to multiple pollen species. I. Clinical and immunologic characteristics.

Bousquet J, Hejjaoui A, Becker WM, Cour P, Chanal I, Lebel B, Dhivert H, Michel FB. Bousquet J, et al. J Allergy Clin Immunol. 1991 Mar;87(3):737-46. doi: 10.1016/0091-6749(91)90397-7. J Allergy Clin Immunol. 1991. PMID: 2005328

3

Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid.

Bousquet J, Hejjaoui A, Soussana M, Michel FB. Bousquet J, et al. J Allergy Clin Immunol. 1990 Feb;85(2):490-7. doi: 10.1016/0091-6749(90)90160-6. J Allergy Clin Immunol. 1990. PMID: 2406327 Clinical Trial.

4

Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.

Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T, Braun W. Bufe A, et al. Allergy. 2004 May;59(5):498-504. doi: 10.1111/j.1398-9995.2004.00457.x. Allergy. 2004. PMID: 15080830 Clinical Trial.

5

Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy.

Bousquet J, Maasch H, Martinot B, Hejjaoui A, Wahl R, Michel FB. Bousquet J, et al. J Allergy Clin Immunol. 1988 Sep;82(3 Pt 1):439-46. doi: 10.1016/0091-6749(88)90017-6. J Allergy Clin Immunol. 1988. PMID: 3170992 Clinical Trial.

6

Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extract.

Bousquet J, Hejjaoui A, Skassa-Brociek W, Guérin B, Maasch HJ, Dhivert H, Michel FB. Bousquet J, et al. J Allergy Clin Immunol. 1987 Oct;80(4):591-8. doi: 10.1016/0091-6749(87)90013-3. J Allergy Clin Immunol. 1987. PMID: 3668124 Clinical Trial.

7

Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.

Reich K, Gessner C, Kroker A, Schwab JA, Pohl W, Villesen H, Wüstenberg E, Emminger W. Reich K, et al. Clin Ther. 2011 Jul;33(7):828-40. doi: 10.1016/j.clinthera.2011.06.006. Epub 2011 Jul 7. Clin Ther. 2011. PMID: 21741092 Clinical Trial.

8

Both sublingual and supralingual routes of administration are effective in long-term allergen-specific immunotherapy.

Panzner P, Petráš M, Sýkora T, Lesná IK, Liška M. Panzner P, et al. Allergy Asthma Proc. 2011 Mar-Apr;32(2):142-50. doi: 10.2500/aap.2011.32.3423. Allergy Asthma Proc. 2011. PMID: 21439167 Clinical Trial.

9

Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.

Pfaar O, Wolf H, Klimek L, Schnitker J, Wüstenberg E. Pfaar O, et al. Clin Ther. 2012 Oct;34(10):2072-81. doi: 10.1016/j.clinthera.2012.09.006. Clin Ther. 2012. PMID: 23063373 Clinical Trial.

10

Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.

Panzner P, Petrás M, Sýkora T, Lesná I. Panzner P, et al. Respir Med. 2008 Sep;102(9):1296-304. doi: 10.1016/j.rmed.2008.03.024. Epub 2008 Jun 27. Respir Med. 2008. PMID: 18585908 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

202 results

Results by year